Hanmi eyes growth through strategic alliances

Published: 2009-05-18 07:00:00

Updated: 2009-05-18 07:00:00

Business sources say that a number of domestic pharmaceutical firms have recently established strategic alliances with multinationals for co-marketing and co-development of new drugs to effectively minimize outlays for sales and development and new drugs.

Hanmi Pharm has put forward another st...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK